Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group.
| Autor: | Ferrari, M D, Wilkinson, M, Hirt, D, Lataste, X, Notter, M, Ferrari, Michel D, Wilkinson, Marcia, Hirt, Dorothea, Lataste, Xavier, Notter, Marianne, ICS 205-930 Migraine Study Group |
|---|---|
| Zdroj: | PAIN; 1991 Jun, Vol. 45 Issue 3, p283-291, 9p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|